Acute Myeloid Leukemia - Epidemiology Forecast to 2029

Publisher Name :
Date: 29-Jun-2020
No. of pages: 37

Acute Myeloid Leukemia - Epidemiology Forecast to 2029

Summary

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow in which the bone marrow produces abnormal red blood cells, white blood cells, or platelets, and generally progresses at a rapid pace. AML is more common in the elderly, is associated with severe complications and high mortality, and accounts for a disproportionately high number of cancer-related deaths. AML is often called acute myelogenous leukemia, acute myeloblastic leukemia, acute granulocytic leukemia, and acute nonlymphocytic leukemia.

In 2019, there were 72,164 diagnosed incident cases of AML in the 8MM in men and women combined for ages 18 years and older. GlobalData epidemiologists estimate that globally, cases will rise to 90,264 at an Annual Growth Rate (AGR) of 2.51% by 2029. Urban China is expected to contribute the highest proportion of growth over this forecast period with diagnosed incident cases growing from 29,535 in 2019 to 39,991 in 2029 at an AGR of 3.54%. Similarly, the five-year diagnosed prevalent cases of AML in the 8MM are expected to grow from 99,624 cases to 124,065 cases by 2029.

Scope

- This report provides an overview of the risk factors, comorbidities, and global and historical trends for AML in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). It includes a 10-year epidemiological forecast for the diagnosed incident cases of AML segmented by sex, and age by 10-year age groups beginning at age 18 years. The diagnosed incident cases of AML are also segmented by prognostic risk group (favorable-risk, intermediate-risk, and high-risk), and by type (secondary AML and acute promyelocytic leukemia [APL]).

- Additionally, this forecast provides the five-year diagnosed prevalent cases of AML. The accompanying epidemiology forecast model includes additional analysis on the diagnosed incident cases of AML, with associated mutations and biomarkers FLT3, IDH1, IDH2, BCR-ABL1/t(9;22)(q34.1;q11.2) translocation, CD-33, and CBF-AML with KIT mutation.

- The AML epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to Buy

The AML Epidemiology series will allow you to -

- Develop business strategies by understanding the trends shaping and driving the global AML market.

- Quantify patient populations in the global AML market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for AML therapeutics in each of the markets covered.

- Understand magnitude of secondary AML and APL.

Acute Myeloid Leukemia - Epidemiology Forecast to 2029

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 AML: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources Used and Not Used
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for AML (2019-2029)
3.5.1 Diagnosed Incident Cases of AML
3.5.2 Age-Specific Diagnosed Incident Cases of AML
3.5.3 Sex-Specific Diagnosed Incident Cases of AML
3.5.4 Diagnosed Incident Cases of AML by Risk Group
3.5.5 Diagnosed Incident Cases of Secondary AML
3.5.6 Diagnosed Incident Cases of APL
3.5.7 Five-Year Diagnosed Prevalent Cases of AML
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Coronavirus Disease 2019 (COVID-19) Impact
3.6.3 Limitations of Analysis
3.6.4 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types and Countries
Table 2: Summary of Updated Data Types
Table 3: Risk Factors for AML

List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of AML, Men and Women, Ages 18 Years and Older, 2019 and 2029
Figure 2: 8MM, Five-Year Diagnosed Prevalent Cases of AML, Men and Women, Ages 18 Years and Older, 2019 and 2029
Figure 3: 8MM, Diagnosed Incidence of AML, Men and Women, Ages 18 Years and Older, 2009-2019
Figure 4: Sources Used to Forecast the Diagnosed Incident Cases of AML
Figure 5: Sources Used to Forecast the Diagnosed Incident Cases of AML by Risk Group
Figure 6: Sources Used to Forecast the Diagnosed Incident Cases of Secondary AML
Figure 7: Sources Used to Forecast the Diagnosed Incident Cases of APL
Figure 8: Sources Used to Forecast the Five-Year Diagnosed Prevalent Cases of AML
Figure 9: 8MM, Diagnosed Incident Cases of AML, Men and Women, Ages ?18 Years, 2019
Figure 10: 8MM, Diagnosed Incident Cases of AML by Age Group, Men and Women, 2019
Figure 11: 8MM, Diagnosed Incident Cases of AML by Sex, Ages ?18 Years, 2019
Figure 12: 8MM, Diagnosed Incident Cases of AML by Risk Group, Men and Women, Ages ?18 Years, 2019
Figure 13: 8MM, Diagnosed Incident Cases of Secondary AML, Men and Women, Ages ?18 Years, 2019
Figure 14: Diagnosed Incident Cases of APL, 8MM, Men and Women, Ages ?18 Years, 2019 and 2029
Figure 15: 8MM, Five-Year Diagnosed Prevalent Cases of AML, Men and Women, Ages ?18 Years, 2019
  • Outlook of Diabetic Macular Edema – Current Landscape and the Way Forward
    Published: 08-Jul-2020        Price: US 4500 Onwards        Pages: 81
    Global market for DME was ~$3.7 billion in 2019 with US alone contributing to 51% market share, owing to the higher incidence rates of diabetes amongst the developed nations. In 2018, ~2.4m people in the US had DME, of that only ~70% got diagnosed and treated. Following is the current treatment paradigm for DME - the first line includes Eylea (Regeneron), Lucentis (Roche/Genentech) and the second line treatment includes short term steroids implants such as dexamethasone (Ozurdex, Allergen; on......
  • 2014-2029 Report on Global Therapeutic Nuclear Medicines Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 115
    The global Therapeutic Nuclear Medicines market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2017 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect......
  • 2014-2029 Report on Global Infertility Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 104
    The global Infertility Drugs market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this indust......
  • 2014-2029 Report on Global Hyaluronic Acid (Sodium +Injection) Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 100
    The global Hyaluronic Acid (Sodium +Injection) market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly ......
  • 2014-2029 Report on Global Chondroitin Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 117
    The global Chondroitin market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in ......
  • 2014-2029 Report on Global Anti-infective Ophthalmic Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 106
    The global Anti-infective Ophthalmic market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect thi......
  • 2014-2029 Report on Global Inulin Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 116
    The global Inulin market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.......
  • 2014-2029 Report on Global Renal Cell Carcinoma Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 108
    The global Renal Cell Carcinoma Drugs market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect th......
  • 2014-2029 Report on Global Anti-tumor Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 119
    The global Anti-tumor Drug market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs